Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous stem cell transplantation for chronic myeloid leukemia.
Mahon FX, Marit G, Boiron JM, Cony-Makhoul P, Agape P, Pigneux A, Broustet A, Reiffers J. Mahon FX, et al. Among authors: agape p. Recent Results Cancer Res. 1998;144:8-14. doi: 10.1007/978-3-642-46836-0_2. Recent Results Cancer Res. 1998. PMID: 9304702 Review. No abstract available.
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study.
Marit G, Thiessard F, Faberes C, Cony-Makhoul P, Boiron JM, Bernard P, Pigneux A, Puntous M, Agape P, Vezon G, Broustet A, Girault D, Salmi LR, Reiffers J. Marit G, et al. Among authors: agape p. Leukemia. 1998 Sep;12(9):1447-56. doi: 10.1038/sj.leu.2401105. Leukemia. 1998. PMID: 9737695
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
Lowenthal RM, Fabères C, Marit G, Boiron JM, Cony-Makhoul P, Pigneux A, Agape P, Vezon G, Bouzgarou R, Dazey B, Fizet D, Bernard P, Lacombe F, Reiffers J. Lowenthal RM, et al. Among authors: agape p. Bone Marrow Transplant. 1998 Oct;22(8):763-70. doi: 10.1038/sj.bmt.1701435. Bone Marrow Transplant. 1998. PMID: 9827973
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients.
Fitoussi O, Perreau V, Boiron JM, Bouzigon E, Cony-Makhoul P, Pigneux A, Agape P, Nicolini F, Dazey B, Reiffers J, Salmi R, Marit G. Fitoussi O, et al. Among authors: agape p. Bone Marrow Transplant. 2001 Apr;27(8):837-42. doi: 10.1038/sj.bmt.1702879. Bone Marrow Transplant. 2001. PMID: 11477441 Clinical Trial.
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
Yakoub-Agha I, Mary JY, Hulin C, Doyen C, Marit G, Benboubker L, Voillat L, Moreau P, Berthou C, Stoppa AM, Maloisel F, Rodon P, Dib M, Pegourie B, Casassus P, Slama B, Damaj G, Zerbib R, Harousseau JL, Mohty M, Facon T; Intergroupe Francophone du Myélome (IFM). Yakoub-Agha I, et al. Eur J Haematol. 2012 Mar;88(3):249-59. doi: 10.1111/j.1600-0609.2011.01729.x. Epub 2012 Jan 4. Eur J Haematol. 2012. PMID: 22023551 Clinical Trial.
Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.
Rousselot P, Charbonnier A, Cony-Makhoul P, Agape P, Nicolini FE, Varet B, Gardembas M, Etienne G, Réa D, Roy L, Escoffre-Barbe M, Guerci-Bresler A, Tulliez M, Prost S, Spentchian M, Cayuela JM, Reiffers J, Chomel JC, Turhan A, Guilhot J, Guilhot F, Mahon FX. Rousselot P, et al. Among authors: agape p. J Clin Oncol. 2014 Feb 10;32(5):424-30. doi: 10.1200/JCO.2012.48.5797. Epub 2013 Dec 9. J Clin Oncol. 2014. PMID: 24323036
34 results